Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Coherus Biosciences
company
About
Coherus Biosciences develops, manufactures, and commercializes biologic therapeutics for oncology and inflammatory diseases.
- 251 - 500
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- $54.70M
- Industries
- Biotechnology,Health Care,Manufacturing,Medical,Therapeutics
- Founded date
- Jan 1, 2007
- Number Of Employee
- 251 - 500
- Operating Status
- Active
Coherus Biosciences is a biopharmaceutical company that engages in the development, manufacture, and commercialization of biologic therapeutics. The company develops biologic medicines primarily for the treatment of oncology and inflammatory diseases. It focuses on process science, analytical characterization, protein production, and clinical-regulatory development. Its pipeline includes Immunology, anti-tumor necrosis factor (Anti-TNF) biosimilar candidates; Ophthalmology biosimilar candidates; and Oncology Biosimilar candidates.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$54.70M
Coherus Biosciences has raised a total of
$54.70M
in funding over 2 rounds. Their latest funding was raised on
May 19, 2014 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 19, 2014 | Series C | $54.70M | 1 |
Kohlberg Kravis Roberts
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Coherus Biosciences is funded by 1 investors.
Kohlberg Kravis Roberts
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Kohlberg Kravis Roberts
|
Yes | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
